3079.T Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 09:15):

Stats
Šios dienos apimtis	56 600.00
Vidutinė apimtis	11 800.00
Rinkos kapitalizacija	10.40B
EPS	¥0 ( 2024-01-30 )
Kita pelno data	( ¥0 ) 2024-05-13
Last Dividend	¥30.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	26.11
ATR14	¥1.661 (0.17%)

Tūris Koreliacija

Ilgas: 0.14 (neutral)

Trumpas: -0.25 (neutral)

Signal:(46.626) Neutral

DVx Inc. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

DVx Inc. Koreliacija - Valiuta/Žaliavos

0.27
( neutral )

0.42
( neutral )

-0.42
( neutral )

0.33
( neutral )

0.28
( neutral )

DVx Inc. Finansinės ataskaitos

Annual	2022
Pajamos:	¥47.48B
Bruto pelnas:	¥5.46B (11.49 %)
EPS:	¥90.21

FY	2022
Pajamos:	¥47.48B
Bruto pelnas:	¥5.46B (11.49 %)
EPS:	¥90.21

FY	2022
Pajamos:	¥45.50B
Bruto pelnas:	¥5.34B (11.73 %)
EPS:	¥83.56

FY	2021
Pajamos:	¥41.01B
Bruto pelnas:	¥4.96B (12.09 %)
EPS:	¥55.60

Financial Reports:

No articles found.

DVx Inc. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥0 (N/A)	¥0 (N/A)	¥30.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

DVx Inc. Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 6.93 - average (97.64%) | Divividend Growth Potential Score: 3.61 - Decrease likely (27.84%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥5.00	2010-03-29
Last Dividend	¥30.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	15	--
Total Paid Out	¥229.63	--
Avg. Dividend % Per Year	0.00%	--
Score	2.23	--
Div. Sustainability Score	6.93
Div.Growth Potential Score	3.61
Div. Directional Score	5.27	--

Next Divdend (Est)
(2024-12-31)

¥0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

2.23

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8068.T	Ex Dividend Knight	2024-01-30	Semi-Annually	0.00%
7350.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
6590.T	Ex Dividend Knight	2024-03-28	Annually	0.00%
5936.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
4617.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
3852.T	Ex Dividend Junior	2023-12-28	Annually	0.00%
3093.T	Ex Dividend Knight	2024-02-28	Semi-Annually	0.00%
1967.T	Ex Dividend Junior	2024-03-18	Annually	0.00%
9531.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
8424.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.00861	1.500	9.83	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0175	1.200	9.42	10.00	[0 - 0.3]
returnOnEquityTTM	0.0432	1.500	-0.631	-0.947	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.617	0.800	6.92	5.53	[1 - 3]
quickRatioTTM	1.439	0.800	6.24	4.99	[0.8 - 2.5]
cashRatioTTM	0.563	1.500	7.98	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	3 364.07	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	82.27	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	82.27	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.107	1.000	-1.548	-1.548	[0.2 - 0.8]
operatingProfitMarginTTM	0.0183	1.000	-1.634	-1.634	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	2.03	0.800	10.00	8.00	[0.5 - 2]
Total Score				6.93

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	26.16	1.000	7.46	0	[1 - 100]
returnOnEquityTTM	0.0432	2.50	-0.406	-0.947	[0.1 - 1.5]
freeCashFlowPerShareTTM	82.27	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	5.02	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	82.27	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	1.833	1.500	1.114	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0186	1.000	-2.03	0	[0.1 - 0.5]
Total Score				3.61

DVx Inc.

DVx Inc. engages in the import/export of medical devices and related peripheral devices in Japan. The company sells arrhythmia-related products, such as cardiac pacemakers, implantable cardioverter defibrillators, electrode catheters, and ablation catheters. It also offers ischemia-related products, including excimer laser systems; RADPAD, which reduces scatter radiation exposure to medical personnel during fluoroscopy procedures; RADNEK that reduces scatter radiation exposure to the thyroid in medical personnel during fluoroscopy procedures; RADCAP, which reduces scatter radiation exposure to the head of medical personnel during fluoroscopy procedures; and resolution/resolution SD and wonder belt products. In addition, the company engages in the research, development, manufacture, sale, repair, and leasing of medical devices and related peripheral devices; provision of internal and external medical and medical device-related general consulting and services; and medical publishing and market research activities. DVx Inc. was founded in 1986 and is headquartered in Tokyo, Japan.